HIV Medicine

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003
pp. 135-141(7)
Authors: Stöhr, W; Dunn, DT; Porter, K; Hill, T; Gazzard, B; Walsh, J; Gilson, R; Easterbrook, P; Fisher, M; Johnson, MA; Delpech, VC; Phillips, AN; Sabin, CA

Antiviral activity of low-dose alovudine in antiretroviral-experienced patients: results from a 4-week randomized, double-blind, placebo-controlled dose-ranging trial
pp. 142-147(6)
Authors: Ghosn, J; Quinson, A-M; Sabo, ND; Cotte, L; Piketty, C; Dorléacq, N; Bravo, M-L; Mayers, D; Harmenberg, J; Mårdh, G; Valdez, H; Katlama, C

Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells
pp. 148-155(8)
Authors: French, MA; Keane, NM; McKinnon, EJ; Phung, S; Price, P

Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs
pp. 156-163(8)
Authors: Le Moing, V; Thiébaut, R; Chêne, G; Sobel, A; Massip, P; Collin, F; Meyohas, MC; Al Kaïed, F; Leport, C; Raffi, F

Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France
pp. 164-170(7)
Authors: Breton, G; Lewden, C; Spire, B; Salmon, D; Brun-Vézinet, F; Duong, M; Allavena, C; Leport, C; Salamon, R

Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts
pp. 171-180(10)
Authors: Calmy, A; Petoumenos, K; Lewden, C; Law, M; Bocquentin, F; Hesse, K; Cooper, D; Carr, A; Bonnet, F

Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients
pp. 181-185(5)
Authors: Ho, CF; Lee, SS; Wong, KH; Cheng, LS; Lam, MY

National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral-naïve patients
pp. 186-191(6)
Authors: Hart, E; Curtis, H; Wilkins, E; Johnson, M

Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment
pp. 192-202(11)
Authors: Thein, HH; Maruff, P; Krahn, M; Kaldor, JM; Koorey, DJ; Brew, BJ; Dore, GJ